Insulin autoantibodies and insulin antibodies have similar binding characteristics

Proceedings of the Association of American Physicians

Volumn 111, Issue 1, 1999, Pages 92-96

  Brooks Worrell, B M ^a   Nielson, D ^a   Palmer, J P ^a  

^a Endocrinology   (United States)

Author keywords

Humoral response; Insulin autoantibodies; Type 1 diabetes

Indexed keywords

INSULIN ANTIBODY; INSULIN RECEPTOR ANTIBODY;

ANTIGEN BINDING; CLINICAL ARTICLE; CONFERENCE PAPER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; PANCREAS ISLET BETA CELL; SCATCHARD PLOT;

EID: 0032906708     PISSN: 1081650X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1381.1999.09114.x     Document Type: Conference Paper

References (23)

1. 1 Lernmark A. Islet cell antibodies. Diabet. Med. 4: 285 292, 1987.
2. 2 Palmer J.P., Asplin C.M., Clemons P., et al. Insulin antibodies in insulin‐dependent diabetics before insulin treatment. Science 222: 1337 1339, 1983.
3. 3 Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619 633, 1965.
4. 4 Bingley P.J., Bonifacio E., Williams A.J.K., et al. Prediction of IDDM in the general population: Strategies based on combinations of autoantibody markers. Diabetes 11: 1701 1710, 1997.
5. 5 Palmer J.P. Predicting IDDM. Use of humoral immune markers. Diabetes Rev. 1: 104 –115, 1993.
6. 6 Hegewald M.J., Schoenfeld S.L., McCulloch D.K., et al. Increased specificity and sensitivity of insulin autoantibody measurements in autoimmune thyroid disease and type I diabetes. J. Immunol. Methods 1154: 61 68, 1992.
7. 7 Greenbaum C.J., Brooks‐Worrell B.M., Palmer J.P., and Lernmark A. Autoimmunity and prediction of insulin dependent diabetes mellitus. In: Marshall S.M. and Home P.D. (eds). Diabetes Annual 8. New York: Elsevier Science BV, 1994. Pp. 21.
8. 8 Fineberg S.E., Biegel A.A., Durr K.L., et al. Presence of insulin autoantibodies as a regular feature of nondiabetic repertoire of immunity. Diabetes 40: 1187 1193, 1991.
9. 9 Sodoyez J.C., Sodoyez‐Goffaux F., Koch M., et al. Clonally restricted insulin autoantibodies in a cohort of 2200 healthy blood donors. Diabetologia 33: 719 725, 1990.
10. 10 Ikematsu H., Ichiyoshi Y., Schettino E.W., et al. VH and VK segment structure of anti‐insulin IgG autoantibodies in patients with insulin‐dependent diabetes mellitus. Evidence for somatic selection. J. Immunol. 152: 1430 1441, 1994.
11. 11 Greenbaum C.J., Palmer J.P., Kuglin B., et al. Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin‐dependent diabetes mellitus than those measured by enzyme‐linked immunosorbent assay: Results of the fourth international workshop on the standardization of insulin autoantibody measurement. J. Clin. Endocrinol. Metabol. 74: 1040 1044, 1992.
12. 12 Vahasalo P. Autoantibodies to insulin have similar affinity to that of antibodies to exogenous insulin but lower binding cpaacity. Eur. J. Clin. Invest. 22: 772 776, 1992.
13. 13 Sutton M., Klaff L.F., Asplin C.M., et al. Insulin autoantibodies at diagnosis of insulin‐dependent diabetes: Effect on the antibody response to insulin treatment metabolism. Metabolism 37: 1005 1007, 1988.
14. 14 McPherson G.A. Analysis of radioligand binding experiments: A collection of computer programs for the IBM PC. J. Pharmacol. Meth. 14: 213 228, 1986.
15. 15 Siminovitch K.A. and Chen P.P. B cells, immunoglobulin genes and variable gene utilization by autoantibodies. In: Bona C.A., Siminovitch K.A., Zanetti M., and Theofilopoulos A.N. (eds). The Molecular Pathology of Autoimmune Diseases. Philadelphia: Harwood Academic, 1993. Pp. 15.
16. 16 Shomchik M.J., Marshak‐Rothstein A., Wolfowicz C.B., et al. The role of clonal selection and somatic mutation in autoimmunity. Nature 328: 805 811, 1987.
17. 17 Ray S.K., Putterman C., Diamond B. Pathogenic autoantibodies are routinely generated during the response to foreign antigen: A paradigm for autoimmune disease. Proc Natl Acad Sci USA 93: 2019 2024, 1995.
18. 18 Nakamura M., Burastero S.E., Ueki Y., et al. Probing the normal and autoimmune B cell repertoire with Epstein‐Barr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto’s disease and systemic lupus erythematosus. J. Immunol. 141: 4165 4172, 1988.
19. 19 Liao L., Sindhwani R., Rojkind M., et al. Antibody‐mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J. Exp. Med. 181: 1123 1131, 1995.
20. 20 Wasada T., Eguchi Y., Takayama S., et al. Insulin autoimmune syndrome associated with benign monoclonal gammopathy. Evidence of monoclonal insulin autoantibodies. Diabetes Care 12: 147 150, 1989.
21. 21 Diaz J.L. & Wilkin T. Differences in epitope restriction of autoantibodies to native human insulin (IAA) and antibodies to heterologous insulin (IA). Diabetes 36: 66 72, 1987.
22. 22 Uchigata Y., Tokunaga K., Nepom G., et al. Differential immunogenetic determinants of polyclonal insulin autoimmune disease (Hirata’s disease) and monoclonal insulin autoimmune syndrome. Diabetes 44: 1227 1232, 1995.
23. 23 Castano L., Ziegler A.G., Ziegler R., et al. Characterization of insulin autoantibodies in relatives of patients with type I diabetes. Diabetes 42: 1202 1209, 1993.